|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.980 USD | -4.33% |
|
-6.57% | -68.92% |
| Market Cap | 2.74Cr 2.39Cr 2.2Cr 2.05Cr 3.89Cr 260.8Cr 3.95Cr 26Cr 10Cr 127.92Cr 10Cr 10Cr 440.77Cr | P/E 2026 * |
-1.01x | P/E 2027 * | -1.66x |
|---|---|---|---|---|---|
| Enterprise Value | 2.74Cr 2.39Cr 2.2Cr 2.05Cr 3.89Cr 260.8Cr 3.95Cr 26Cr 10Cr 127.92Cr 10Cr 10Cr 440.77Cr | EV / Sales 2026 * |
4.35x | EV / Sales 2027 * | 1.43x |
| Free-Float |
98.37% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Plus Therapeutics, Inc.
| 1 day | -4.33% | ||
| 1 week | -6.57% | ||
| Current month | -8.92% | ||
| 1 month | -27.24% | ||
| 3 months | +11.80% | ||
| 6 months | -71.32% | ||
| Current year | -68.92% |
| 1 week | 3.84 |  | 4.51 |
| 1 month | 3.84 | | 6.03 |
| Current year | 2.9 | | 15.32 |
| 1 year | 2.9 | | 23.42 |
| 3 years | 2.9 | | 80.25 |
| 5 years | 2.9 | | 975 |
| 10 years | 2.9 | | 4,29,377.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 64 | 02/04/2014 |
Andrew Sims
DFI | Director of Finance/CFO | 52 | 06/02/2020 |
Daniel Ortega
CTO | Chief Tech/Sci/R&D Officer | - | 21/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Marc Hedrick
BRD | Director/Board Member | 64 | 01/10/2002 |
Richard Hawkins
CHM | Chairman | 77 | 25/01/2018 |
| Director/Board Member | 66 | 01/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/07 | Fiscal year | Chief Financial Officer | 5,970 | 0.0870% | ||
| 01/07 | Fiscal year | Chief Executive Officer | 32,878 | 0.4791% | ||
| 01/07 | Fiscal year | Chairman | 1,844 | 0.0269% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.33% | -6.57% | -48.18% | -92.12% | 2.74Cr | |
| +0.27% | +5.91% | +1.69% | +6.95% | 4.91TCr | |
| +0.92% | +6.21% | +408.85% | +607.44% | 4.02TCr | |
| +1.89% | +11.06% | +25.75% | -7.89% | 3.46TCr | |
| +2.38% | +8.10% | +21.83% | +66.94% | 3.31TCr | |
| +1.20% | +2.02% | +9.79% | +32.43% | 2.52TCr | |
| +2.51% | +4.94% | - | - | 1.7TCr | |
| +2.58% | +7.24% | +71.03% | +132.17% | 1.59TCr | |
| -0.38% | -0.12% | +12.88% | +18.27% | 1.38TCr | |
| -1.14% | +7.52% | +14.75% | -30.83% | 1.33TCr | |
| Average | +0.59% | +5.13% | +57.60% | +81.48% | 2.42TCr | |
| Weighted average by Cap. | +1.19% | +6.73% | +88.32% | +130.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.95L 55.01L 50.51L 47.11L 89.3L 60Cr 90.81L 6.08Cr 2.36Cr 29Cr 2.36Cr 2.31Cr 101.29Cr | 1.91Cr 1.67Cr 1.54Cr 1.43Cr 2.72Cr 182.22Cr 2.76Cr 18Cr 7.17Cr 89Cr 7.19Cr 7.03Cr 307.97Cr |
| Net income | -2.68Cr -2.34Cr -2.15Cr -2.01Cr -3.8Cr -255.14Cr -3.87Cr -26Cr -10Cr -125.14Cr -10Cr -9.84Cr -431.21Cr | -1.85Cr -1.61Cr -1.48Cr -1.38Cr -2.62Cr -175.69Cr -2.66Cr -18Cr -6.91Cr -86Cr -6.93Cr -6.78Cr -296.93Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | $3.980 | -4.33% | 2,23,232 |
| 01/26/01 | $4.160 | -4.81% | 1,39,275 |
| 30/26/30 | $4.370 | +1.86% | 1,64,417 |
| 29/26/29 | $4.290 | +2.14% | 2,51,001 |
| 26/26/26 | $4.200 | -1.41% | 2,86,155 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PSTV Stock
Select your edition
All financial news and data tailored to specific country editions
